What are names of DPP-4 inhibitors?

What are names of DPP-4 inhibitors?

Medicines in the DPP-4 inhibitor class include sitagliptin, saxagliptin, linagliptin, and alogliptin.

What does a DPP-4 inhibitor do?

DPP-4 inhibitors lower blood sugar by helping the body increase the level of the hormone insulin after meals. Insulin helps move sugar from the blood into the tissues so the body can use the sugar to produce energy and keep blood sugar levels stable.

What is the best DPP-4 inhibitors?

“Of the three DPP-4 inhibitors, sitagliptin appears to have the safest cardiovascular profile,” states Dr Scirica.

Is Januvia a DPP-4?

Called DPP-4 inhibitors, these drugs work in a way that is different from any previous diabetes treatment. Sitagliptin (brand name Januvia) was the first drug in this class to be approved; it can be used alone or in combination with other oral diabetes drugs.

Which is better linagliptin or vildagliptin?

Moreover, as far as we know, this study is the first to compare vildagliptin, sitagliptin, and linagliptin as add-on therapy for T2DM patients with background insulin treatment. And what is more, our results indicate that vildagliptin is more effective in decreasing HbA1c.

Is Victoza and Januvia the same?

What are Victoza and Januvia? Victoza is an injectable medicine, while Januvia is an oral tablet. Both drugs are used once a day, in addition to diet and exercise, to help control blood sugar levels in patients with type 2 diabetes.

Is Januvia a GLP-1 drug?

The selection of a GLP-1 agonist (like Victoza) OR a DPP-4 inhibitor (like Januvia) as a second-line agent may be appropriate in patients without established cardiovascular risk factors but in need of an agent that won’t significantly lower blood sugar (cause hypoglycemia).

Which is better Januvia or Victoza?

Victoza. April 22, 2010 — Type 2 diabetes patients who took the new once-a-day injectable drug Victoza achieved better blood sugar control and lost more weight than patients who took the widely prescribed oral drug Januvia, a study shows.

  • October 10, 2022